Increased expression of integrin αvβ5 induces the myofibroblastic differentiation of dermal fibroblasts

被引:149
作者
Asano, Y
Ihn, H
Yamane, K
Jinnin, M
Tamaki, K
机构
[1] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Dermatol & Plast & Reconstruct Surg, Kumamoto 8608556, Japan
[2] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 113, Japan
关键词
D O I
10.2353/ajpath.2006.041306
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The biological effect of cytokines is mainly determined by the cytokine-receptor interaction, which is modulated by the concentration and the activity of cytokines and/or their receptors. Because alpha v-containing integrins can bind to and/or activate latent TGF-beta, these integrins have been thought to he involved in the pathogenesis of fibrotic disorders. Our recent observations that alpha v beta 5 is up-regulated in scleroderma fibroblasts and that the transient overexpression of alpha v beta 5 increases the human alpha 2(I) collagen gene expression in normal fibroblasts suggest the involvement of alpha v beta 5 in the self-activation system in scleroderma fibroblasts. In this study, we established stable transfectants with alpha v beta 5 using normal dermal fibroblasts and demonstrated that such cells differentiated into myofibroblasts by the stimulation of autocrine TGF-beta. This observation is explained by 1) alpha v beta 5 recruiting latent TGF-beta 1 on the cell surface, 2) endogenous active TGF-beta localizing on the cell surface, and 3) alpha v beta 5 interacting with. TGF-beta receptors. Furthermore, blockade of alpha v beta 5 reversed the myofibroblastic phenotype in scleroderma fibroblasts. These data identify a novel mechanism for the establishment of autocrine TGF-beta signaling in dermal fibroblasts by the up-regulation of alpha v beta 5 and suggest the possibility of regulating fibrotic disorders, especially scleroderma, by targeting this integrin.
引用
收藏
页码:499 / 510
页数:12
相关论文
共 51 条
  • [1] AN ASSAY FOR TRANSFORMING GROWTH-FACTOR-BETA USING CELLS TRANSFECTED WITH A PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROMOTER LUCIFERASE CONSTRUCT
    ABE, M
    HARPEL, JG
    METZ, CN
    NUNES, I
    LOSKUTOFF, DJ
    RIFKIN, DB
    [J]. ANALYTICAL BIOCHEMISTRY, 1994, 216 (02) : 276 - 284
  • [2] Distinct endocytic responses of heteromeric and homomeric transforming growth factor beta receptors
    Anders, RA
    Arline, SL
    Dore, JJE
    Leof, EB
    [J]. MOLECULAR BIOLOGY OF THE CELL, 1997, 8 (11) : 2133 - 2143
  • [3] Differential requirement for type I and type II transforming growth factor β receptor kinase activity in ligand-mediated receptor endocytosis
    Anders, RA
    Dore, JE
    Arline, SL
    Garamszegi, N
    Leof, EB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 23118 - 23125
  • [4] Making sense of latent TGFβ activation
    Annes, JP
    Munger, JS
    Rifkin, DB
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (02) : 217 - 224
  • [5] Increased expression levels of integrin αvβ5 on scleroderma fibroblasts
    Asano, Y
    Ihn, H
    Yamane, K
    Kubo, M
    Tamaki, K
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) : 1275 - 1292
  • [6] TRANSFORMING GROWTH-FACTOR-BETA IN DISEASE - THE DARK SIDE OF TISSUE-REPAIR
    BORDER, WA
    RUOSLAHTI, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (01) : 1 - 7
  • [7] Platelet-derived growth factor receptor β and vascular endothelial growth factor receptor 2 bind to the β3 integrin through its extracellular domain
    Borges, E
    Jan, YW
    Ruoslahti, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) : 39867 - 39873
  • [8] BRUNET CL, 1995, INT J DEV BIOL, V39, P345
  • [9] BUCKINGHAM RB, 1978, J LAB CLIN MED, V92, P5
  • [10] Thrombospondin-1 is a major activator of TGF-β1 in vivo
    Crawford, SE
    Stellmach, V
    Murphy-Ullrich, JE
    Ribeiro, SMF
    Lawler, J
    Hynes, RO
    Boivin, GP
    Bouck, N
    [J]. CELL, 1998, 93 (07) : 1159 - 1170